RRBP1 and neoplasm: The identification of specific and recurrent genetic alterations in HES suggests the possible use of molecularly targeted therapies that have proven to be successful in many tumor types, as this approach selectively kills neoplastic cells that harbor a specific molecular hallmark [138,139,140,141,142,143,144].